GMED

Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total revenue 657.29 M598.12 M745.34 M769.05 M826.42 M 2.94 B Gross profit 393.86 M402.72 M496.58 M516.51 M565.31 M 1.98 B Operating expenses 456.36 M311.76 M411.83 M381.94 M492.81 M 1.6 B Selling/general/admin expenses 252.85 M242.8 M303.62 M313.6 M318.48 M 1.18 B Research & development 33.41 M33.06 M39.95 M38.07 M36.16 M 147.25 M Operating income 60.27 M97 M76.11 M137.36 M169.34 M 479.82 M Non-Operating Income, Total -35.61 M6.66 M112.06 M6.63 M-107 K 125.25 M Interest expense, net of interest capitalized 29 K13 K4 0009 00012 K 38 K Non-Operating Income, excl. Interest Expenses -36.7 M5.94 M111.29 M5.08 M-510 K 121.8 M Unusual income/expense 1.07 M713 K772 K1.54 M391 K 3.41 M Pretax income 24.67 M103.67 M188.17 M143.99 M169.23 M 605.07 M Equity in earnings ————— — Taxes -1.84 M28.21 M-14.67 M25.03 M28.64 M 67.2 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 26.5 M75.46 M202.85 M118.97 M140.59 M 537.87 M Discontinued operations ————— — Net income 26.5 M75.46 M202.85 M118.97 M140.59 M 537.87 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 26.5 M75.46 M202.85 M118.97 M140.59 M 537.87 M Basic earnings per share (Basic EPS) 0.20.551.50.881.05 3.98 Diluted earnings per share (Diluted EPS) 0.190.541.490.881.01 3.92 Average basic shares outstanding 135.73 M136.76 M135.21 M134.5 M135.22 M 541.68 M Diluted shares outstanding 137.86 M139.77 M136.5 M135.39 M137.06 M 548.72 M EBITDA 5.72 M157.04 M155.38 M205.7 M141.51 M 659.64 M EBIT -62.51 M90.97 M84.75 M134.58 M72.5 M 382.8 M Cost of revenue 263.44 M195.4 M248.76 M252.53 M261.11 M 957.8 M Other cost of goods sold 7.17 M5.96 M4.97 M5.05 M6.13 M 22.12 M Depreciation & amortization (cash flow) 68.23 M66.07 M70.63 M71.13 M69.01 M 276.84 M